Apria, Inc. (APR)

Apria, Inc. (APR) Healthcare & Pipeline Overview

Apria, Inc. delivers integrated home healthcare solutions, specializing in respiratory therapies and sleep apnea devices. Operating within the U.S. market, Apria provides essential equipment and support services, addressing the growing demand for in-home medical care and positioning itself as a key player in the medical supplies industry.

What Is the Investment Thesis for APR?

Apria, Inc. presents a focused investment opportunity within the expanding home healthcare sector. The company's specialization in respiratory therapies and sleep apnea devices aligns with the increasing prevalence of chronic respiratory conditions and sleep disorders. Apria's established infrastructure for providing home-based medical equipment and support services positions it to capitalize on the growing demand for convenient and cost-effective healthcare solutions. With a gross margin of 70.2% and a profit margin of 5.7%, Apria demonstrates solid profitability. Key growth catalysts include expanding its product offerings, penetrating new geographic markets, and leveraging technological advancements to enhance patient care and streamline operations. However, potential risks include regulatory changes, reimbursement pressures, and competition from other home healthcare providers. As of March 2026, Apria's parent company, Byram Healthcare Centers, Inc., is likely focused on integrating Apria's operations and extracting synergies.

Based on FMP financials and quantitative analysis

APR Key Highlights

• Apria, Inc. specializes in integrated home healthcare equipment and related services.
• The company provides home respiratory therapies, including oxygen equipment and non-invasive ventilators.
• Apria offers obstructive sleep apnea therapy devices such as CPAP and BiPAP machines.
• They also provide negative pressure wound therapy products.
• As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.

Who Are APR's Competitors?

APR is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are APR's Key Strengths?

• Comprehensive range of home healthcare equipment and services.
• Specialized expertise in respiratory therapies and sleep apnea devices.
• Established relationships with healthcare providers and payers.
• Operating as a subsidiary of Byram Healthcare Centers, Inc.

What Are APR's Weaknesses?

• Dependence on reimbursement rates from insurance companies and government payers.
• Exposure to regulatory changes in the healthcare industry.
• Competition from other home healthcare providers and medical equipment suppliers.
• Potential for product recalls or liability claims.

What Could Drive APR Stock Higher?

• Integration with Byram Healthcare Centers, Inc. to realize synergies and improve operational efficiency.
• Potential expansion of telehealth services to enhance remote patient monitoring within the next 1-2 years.
• Strategic partnerships with healthcare providers to drive patient referrals within the next year.
• Development of innovative products and services to enhance competitive advantage.

What Are the Key Risks for APR?

• Insider selling — insiders were net sellers of roughly $1.1B recently.
• Changes in reimbursement policies that could reduce revenue.
• Increased competition from other home healthcare providers.
• Economic downturn that could reduce patient demand for services.
• Cybersecurity threats that could compromise patient data.

What Are the Growth Opportunities for APR?

• Expansion of Telehealth Services: Apria can leverage telehealth technologies to enhance remote patient monitoring, provide virtual consultations, and improve adherence to therapy. The telehealth market is projected to reach $55.6 billion by 2027, offering a significant opportunity for Apria to expand its reach and improve patient outcomes. By integrating telehealth into its service offerings, Apria can differentiate itself from competitors and attract a wider patient base. This initiative can be implemented within the next 1-2 years.
• Strategic Partnerships with Healthcare Providers: Collaborating with hospitals, physician groups, and managed care organizations can drive patient referrals and expand Apria's market share. By establishing preferred provider relationships, Apria can gain access to a steady stream of patients requiring home healthcare equipment and services. These partnerships can also facilitate integrated care models, improving coordination and communication between healthcare providers. The timeline for establishing these partnerships is within the next year.
• Development of Innovative Products and Services: Investing in research and development to create innovative home healthcare solutions can drive growth and enhance Apria's competitive advantage. This includes developing next-generation respiratory therapy devices, advanced sleep apnea treatments, and remote monitoring technologies. By staying at the forefront of innovation, Apria can attract new customers and retain existing ones. This is an ongoing process that requires continuous investment and monitoring of market trends.
• Geographic Expansion: Expanding into new geographic markets can significantly increase Apria's revenue and market share. This includes targeting underserved areas with a high prevalence of chronic respiratory conditions and sleep disorders. By establishing a presence in new regions, Apria can reach a wider patient population and diversify its revenue streams. This expansion can be phased in over the next 3-5 years, starting with regions that have favorable demographics and regulatory environments.
• Focus on Value-Based Care: Transitioning to value-based care models can improve patient outcomes and reduce healthcare costs. This involves partnering with payers to develop risk-sharing arrangements that reward Apria for delivering high-quality care and achieving specific clinical outcomes. By demonstrating its ability to improve patient health and reduce costs, Apria can attract more patients and secure favorable reimbursement rates. This transition is an ongoing process that requires collaboration with payers and healthcare providers.

What Opportunities Does APR Have?

• Expansion of telehealth services to enhance remote patient monitoring.
• Strategic partnerships with healthcare providers to drive patient referrals.
• Development of innovative products and services to enhance competitive advantage.
• Geographic expansion into new markets.

What Threats Does APR Face?

• Changes in reimbursement policies that could reduce revenue.
• Increased competition from other home healthcare providers.
• Economic downturn that could reduce patient demand for services.
• Cybersecurity threats that could compromise patient data.

What Are APR's Competitive Advantages?

• Established relationships with healthcare providers and payers.
• Specialized expertise in respiratory therapies and sleep apnea devices.
• Comprehensive range of home healthcare equipment and services.
• Operating as a subsidiary of Byram Healthcare Centers, Inc., providing access to additional resources and expertise.

What Does APR Do?

Apria, Inc., incorporated in 2018, is a provider of integrated home healthcare equipment and related services across the United States. The company's core business revolves around supplying essential medical equipment and support to patients in their homes, enabling them to manage chronic conditions and recover from illnesses in a comfortable and familiar environment. Apria's offerings include a comprehensive range of home respiratory therapies, such as stationary and portable home oxygen equipment, and non-invasive ventilators, catering to individuals with respiratory ailments. Additionally, Apria provides obstructive sleep apnea therapy devices, including continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) devices, along with patient support services to ensure effective treatment and adherence. The company also offers negative pressure wound therapy products, addressing the needs of patients requiring advanced wound care at home. Beyond these specialized therapies, Apria provides a range of home medical equipment and other products and services for patients with various home care needs. These include mobility aids, bathroom safety equipment, and other essential items that enhance patients' independence and quality of life. Apria also offers clinical and administrative support services, along with related products and supplies, to ensure patients receive comprehensive care and support. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc., further solidifying its position in the home healthcare market.

What Products and Services Does APR Offer?

• Provides home respiratory therapies, including oxygen equipment and ventilators.
• Offers obstructive sleep apnea therapy devices, such as CPAP and BiPAP machines.
• Supplies negative pressure wound therapy products.
• Provides home medical equipment and related services.
• Offers clinical and administrative support services to patients.
• Delivers products and supplies to patients with home care needs.

How Does APR Make Money?

• Generates revenue through the sale and rental of home medical equipment.
• Receives reimbursement from insurance companies and government payers for services provided.
• Offers clinical and administrative support services to patients, generating additional revenue.
• Operates as a subsidiary of Byram Healthcare Centers, Inc.

What Industry Does APR Operate In?

Apria, Inc. operates within the growing home healthcare market, driven by an aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. The market for home medical equipment is expected to continue expanding, fueled by technological advancements and the desire for patients to receive care in the comfort of their homes. The competitive landscape includes other home healthcare providers, medical equipment suppliers, and durable medical equipment (DME) companies. Apria's focus on respiratory therapies and sleep apnea devices positions it within a specialized segment of the market.

Who Are APR's Key Customers?

• Patients with chronic respiratory conditions, such as COPD and asthma.
• Individuals with obstructive sleep apnea.
• Patients requiring wound care at home.
• Hospitals and healthcare providers referring patients for home healthcare services.

Net sellingInsider Activity

The most recent 12 insider filings for Apria, Inc. break down as 10 sales and 2 purchases. On net that is roughly 28.5M shares disposed (about $1.1B), a signal worth weighing alongside the fundamentals.

APR Valuation & Market Position

Relative to its peer group, APR's quantitative score of 52/100 is roughly in line with the peer average of 53/100.

P/E 20.1Key Financial Metrics

Return on assets is 8.5%, showing how much profit it generates from its asset base. APR trades at a trailing price-to-earnings ratio of 20.11, below the Healthcare sector average of ~23x. A current ratio of 1.09 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.0%, the inverse of the P/E and a quick read on earnings relative to price.

3/4 beatsEarnings Track Record

Apria, Inc. has beaten Wall Street's EPS estimate in 3 of its last 4 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 7.6% above estimates on average.

Company Profile

Apria, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Lake Forest, US. The company is led by CEO Daniel J. Starck. APR has traded publicly since 2021.

APR Financials

APR Latest News

APR Analyst Consensus

APR MoonshotScore

What Investors Ask About Apria, Inc. (APR) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources